Same protocol, different continents, different patients: should we continue to conduct global heart failure trials?, European Journal of Heart Failure, vol.309, issue.9, pp.875-878, 2015. ,
DOI : 10.1002/ejhf.335
International differences in treatment effect: do they really exist and why????, European Heart Journal, vol.34, issue.24, pp.1846-1852, 2013. ,
DOI : 10.1093/eurheartj/eht071
Geographic variations in the PARADIGM-HF heart failure trial, European Heart Journal, vol.37, issue.41, 2016. ,
DOI : 10.1093/eurheartj/ehw226
Angiotensin???Neprilysin Inhibition versus Enalapril in Heart Failure, PARADIGM-HF Investigators and Committees, pp.993-1004, 2014. ,
DOI : 10.1056/NEJMoa1409077
A polymorphism within a conserved beta1-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure, Proceedings of the National Academy of Sciences, vol.103, issue.30, pp.11288-11293, 2006. ,
DOI : 10.1073/pnas.0509937103
Genetic variation in CYP4A11 and blood pressure response to mineralocorticoid receptor antagonism or ENaC inhibition: an exploratory pilot study in African Americans, Journal of the American Society of Hypertension, vol.8, issue.7, pp.475-480, 2014. ,
DOI : 10.1016/j.jash.2014.04.011
Geographic differences in heart failure trials, European Journal of Heart Failure, vol.1, issue.9, pp.893-905, 2015. ,
DOI : 10.1002/ejhf.326
Globalization of cardiovascular clinical research: The balance between meeting medical needs and maintaining scientific standards, American Heart Journal, vol.154, issue.2, pp.232-238, 2007. ,
DOI : 10.1016/j.ahj.2007.04.028
Regional Differences in Heart Failure With Preserved Ejection Fraction Trials: When Nephrology Meets Cardiology but East Does Not Meet West, Circulation, vol.131, issue.1, pp.7-10, 2015. ,
DOI : 10.1161/CIRCULATIONAHA.114.013637
Spironolactone for Heart Failure with Preserved Ejection Fraction, New England Journal of Medicine, vol.370, issue.15, pp.1383-1392, 2014. ,
DOI : 10.1056/NEJMoa1313731
Geographic variation in heart failure trials: time for scepticism?, European Journal of Heart Failure, vol.11, issue.6, pp.601-602, 2014. ,
DOI : 10.1002/ejhf.112
Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions, Heart Failure Reviews, vol.58, issue.9, pp.135-152, 2014. ,
DOI : 10.1007/s10741-012-9361-8
Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial, Circulation, vol.124, issue.5, pp.544-554, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.111.047498
Challenges of subgroup analyses in multinational clinical trials: Experiences from the MERIT-HF trial, American Heart Journal, vol.142, issue.3, pp.502-511, 2001. ,
DOI : 10.1067/mhj.2001.117600
Effectiveness of Valsartan/Amlodipine Single-pill Combination in Hypertensive Patients With Excess Body Weight, Journal of Cardiovascular Pharmacology, vol.66, issue.5, pp.497-503, 2015. ,
DOI : 10.1097/FJC.0000000000000301